Table 1 Reported cases of CEIHs
Author | Age (years) | Sex | Initial Bleeding | Locat-ion | Embo-lization | Radio- surgery Source | Marginal Dose (Gy)a | RIC/ RNb | Cyst | Years post SRS | Symptoms | MR Imaging | AVM Complete Obliteration | Treatment | Outcomeb |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1996 Kurita [7] | 23 | M | + | IC | – | GKS | 20 | RN | – | 2 | HH, N/V | ns | – | Hematoma evacuation, Excision | Improvement |
2006 Maruyama [15] | 51 | M | – | BG | – | GKS | 22,5 | – | – | 6 | HH | Hypo L | – | Excision | Improvement |
2008 Motegi [8] | 47 | M | – | BG | – | Linac | 25 | – | + | 7,5 | HH | HR, Het L, Nod E | + | Excision | Improvement |
2008 Pan [16] | 10 | M | ns | L | – | GKS twice | ns | – | – | 5 | HH, HP | Het L | + | Excision | Improvement |
2009 Takeuchi [1] | 15 | F | + | BG | – | Linac | ns | – | + | 7 | HP | HR, Het L | + | Ommaya Reservoir | Improvement |
2010 Nakazimo [17] | 57 | M | – | BG | – | GKS | 22,5 | – | + | 5 | AS | ns | – | Excision | Stable |
2010 Nakamizo [17] | 55 | M | – | L | – | Linac | 20 | – | – | 11 | HP | HR, Hypo L | + | Excision | Improvement |
2010 Nakamizo [17] | 15 | F | + | BG | + | GKS | 18 | RIC | – | 3 | HH, HP, Vis | HR, Hypo L | – | Steroids, Excision | Improvement |
2011 Lee [18] | 10 | M | + | L | – | GKS twice | 18a | – | – | 5 | HP, Vis | HR, Het L, Multi Nod E | + | Excision | Improvement |
2011 Takeuchi [19] | 49 | M | – | BG | + | Linac | 18 | RN | + | 4 | SD, Memory | Nod E | + | Excision | Improvement |
2014 Watanabe [20] | 34 | F | + | C | – | GKS twice | 22a | RIC | + | 13 | HH, N/V, FP | HR, Hypo L, Nod E | + | Excision | Improvement |
2015 Park [14] | 30 | F | – | L | – | GKS twice | 28a | RIC | – | 7 | HP | Nod E | + | Steroids, Excision | Improvement |
2015 Park [14] | 36 | F | – | L | – | GKS twice | 30a | RIC | – | 7 | HP | HR, Het L | + | Steroids, Excision | Improvement |
2015 Park [14] | 16 | M | – | L | + | GKS | 25 | RIC | – | 3 | HH | HR, Het L | + | Steroids, Excision | Improvement |
2015 Park [14] | 15 | F | – | L | – | GKS three times | 15a | RIC | – | 2 | HP | ns | + | Steroids, Excision | Improvement |
2015 Park [14] | 38 | M | + | BG | – | GKS | 25 | – | + | 12 | HP | ns | + | Steroids, Partial Excision | Worse |
2015 Shuto [21] | 23 | M | + | L | – | GKS | 18 | – | + | 8,1 | S | ns | + | FU, Excision | Improvement |
2015 Shuto [21] | 19 | F | + | L | + | GKS | 18 | – | – | 11,2 | HH | Nod E | + | FU, Excision | Improvement |
2015 Shuto [21] | 33 | M | – | L | + | GKS | 18 | – | + | 4,5 | HP, E | HR, Het L | + | FU, Excision | Improvement |
2015 Shuto [21] | 19 | F | ns | ns | ns | GKS | 28 | – | + | 10,3 | ns | ns | – | FU, Excision | ns |
2015 Shuto [21] | 31 | M | ns | ns | ns | GKS | 25 | – | + | 5 | ns | ns | + | FU, Excision | ns |
2015 Shuto [21] | 24 | M | ns | ns | ns | GKS | 20 | – | + | 1,1 | ns | ns | – | FU, Excision | ns |
2015 Shuto [21] | 56 | F | ns | ns | ns | GKS | 20 | – | + | 12 | ns | ns | + | FU, Excision | ns |
2015 Shuto [21] | 36 | F | ns | ns | ns | GKS | 18 | – | + | 7,9 | ns | ns | + | FU, Excision | ns |
2015 Shuto [21] | 35 | M | ns | ns | ns | GKS | 18 | – | + | 7,1 | ns | ns | + | FU, Excision | ns |
2015 Shuto [21] | 46 | F | ns | ns | ns | GKS | 20 | – | + | 6,2 | ns | ns | + | FU, Excision | ns |
2015 Shuto [21] | 50 | F | ns | ns | ns | GKS | 20 | – | + | 10,1 | ns | ns | + | Lost FU | Lost FU |
2015 Shuto [21] | 47 | M | + | L | – | GKS | 25 | – | + | 6,2 | Vis | Hypo L | + | Lost FU | Lost FU |
2015 Shuto [21] | 17 | F | – | L | – | GKS | 18 | – | + | 3,2 | HH | Nod E | + | Omaya Reservoir, Excision | Improvement |
2016 Takei [22] | 37 | M | + | L | – | ns | ns | – | + | 15 | HH, N/V, AT | HR | + | Partial Excision | Improvement |
2019 D’Aliberti [23] | 55 | F | – | L | + | ns | ns | RIC | – | 12 | HH, N/V | HR, Het L | + | Excision | Improvement |
2019 Hasegawa [24] | 7 | F | ns | L | ns | GKS Twice | 15,5a | – | + | 5 | HP | Het L | – | Excison | Improvement |
Case 1 | 39 | F | + | L | + | Linac | 18 | – | – | 12 | HH | HR, Het L, Multi Nod E | – | FU, Excision | Improvement |
Case 2 | 42 | F | – | L | + | Linac | 18 | RIC | + | 11 | AS | HR, Het L, Nod E | + | Partial Excision | Improvement |
Case 3 | 36 | M | – | L | + | Linac | 18 | RIC | + | 12 | AS | Nod E | + | Cyst evacuation, Excision | Improvement |
Case 4 | 31 | M | – | L | + | Linac | 18 | RIC | + | 10 | HH, SD | HR, Het L | + | Partial Excision | Improvement |
Case 5 | 62 | M | + | L | + | Linac | 18 | – | – | 13 | HP | HR, Het L, Multi Nod E | + | Steroids | Stable |